Purpose of the Study

If you’re considering GLP-1 therapy for Type 2 diabetes, you might be wondering which monitoring tools will work best for you. A new study is looking at how continuous glucose monitoring (CGM) may help manage type 2 diabetes. .

Study Requirements

You may qualify if:

You are 18 or older
You are about to begin a GLP-1 or dual GLP-1/GIP therapy

Potential Benefits of Participation

Maginfying

Access to new treatments that are
not yet available to the general public.

Hand Heart

Personalized medical attention from
leading healthcare professionals.

Helios

Compensation provided to qualified participants

Study Locations

This study is currently enrolling at the following sites:

Helios Clinical Research - Paradise Valley (10565 N. Tatum Blvd, 85253)

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.